Robotic Assisted Endovascular Systems Market Forecast Highlights Expansion From $34.79 Billion To $48.94 Billion Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Robotic Assisted Endovascular Systems Market Revenue Growth Supported By A CAGR Of 48.94% Through 2030
The robotic assisted endovascular systems market has demonstrated robust growth in recent years. Projections indicate it will expand from $32.01 billion in 2025 to $34.79 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.7%. This historical expansion is primarily attributable to an increase in cardiovascular disease cases, the growth in catheter based interventions, the expansion of interventional radiology units, a rising preference for minimally invasive surgery, and improvements in vascular imaging.
The market size for robotic assisted endovascular systems is projected to experience substantial expansion in the coming years. It is forecast to reach $48.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This projected growth throughout the forecast period can be attributed to factors such as the expansion of robotic vascular laboratories, an increasing demand for precision-guided interventions, the broadening of neurovascular robotic procedures, advancements in remote surgery capabilities, and greater hospital investment in robotic suites. Significant trends anticipated during this period include the development of robotic catheter navigation, increased adoption in minimally invasive vascular procedures, the expansion of imaging-guided robotic platforms, a rise in remote robotic interventions, and the integration of precision vascular control systems.
Download A Free Sample Report For Comprehensive Market Insights:
Robotic Assisted Endovascular Systems Market Demand Drivers: What Is Fueling Industry Growth?
The increasing occurrence of cardiovascular and neurovascular diseases is expected to propel the growth of the robotic-assisted endovascular systems market going forward. These conditions, affecting the heart, blood vessels, and brain circulation, include coronary artery disease, stroke, and cerebral aneurysms, and are a leading cause of mortality and long-term disability worldwide. The rise in cardiovascular and neurovascular diseases is attributed to aging populations combined with a higher prevalence of lifestyle-related risk factors such as obesity, hypertension, and physical inactivity. Robotic-assisted endovascular systems assist in managing these diseases by enabling highly precise, minimally invasive navigation of blood vessels, which improves treatment accuracy, safety, and clinical outcomes for complex vascular interventions. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of cardiovascular and neurovascular diseases is driving the growth of the robotic-assisted endovascular systems market.
Robotic Assisted Endovascular Systems Market Segment Analysis: What Are The Major Market Categories?
The robotic assisted endovascular systems market covered in this report is segmented –
1) By Component: Hardware; Software; Services
2) By Product: Robotic Catheter Systems; Robotic Guidewire Systems; Robotic Angioplasty Systems; Other Products
3) By Technology: Robotic Catheter Systems; AI-Assisted Navigation Systems; Imaging-Guided Robotic Platforms; Haptic Feedback Systems; Autonomous Robotic Systems
4) By Application: Coronary Interventions; Peripheral Vascular Interventions; Neurovascular Interventions; Other Applications
5) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Research And Academic Institutes; Other End-Users
Subsegments:
1) By Hardware: Robotic Control Units; Robotic Catheter Systems; Navigation Consoles; Imaging Integration Modules; Surgical Instrument Arms
2) By Software: Navigation Software Platforms; Imaging Processing Software; Procedure Planning Software; Data Management Software; Clinical Decision Support Software
3) By Services: Installation Services; Maintenance And Repair Services; Training And Education Services; System Upgradation Services
Robotic Assisted Endovascular Systems Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading companies in the robotic assisted endovascular systems market are increasingly focusing on integrating robotics with advanced imaging and navigation systems, such as fully remote endovascular robotic platforms. This strategic integration aims to enhance procedural precision, facilitate complex vascular navigation, and expand patient access to specialist care. Fully remote endovascular robotic platforms are characterized as robotic systems that unify real-time fluoroscopic imaging with preoperative CT and MRI data to guide the robotic manipulation of catheters and guidewires during endovascular procedures, simultaneously allowing clinicians to control operations from a remote console. A notable illustration of this trend occurred in October 2025, when Remedy Robotics, a US-based medical technology company, unveiled the Remedy N1 System. This endovascular surgical robotic platform is specifically engineered to support fully remote neurointerventional procedures. Designed to improve accuracy and optimize clinical workflow, the system integrates automated CT and MRI image preprocessing with live fluoroscopic imaging for real-time navigation, permits simultaneous robotic control of up to four endovascular devices, and comes equipped with a portable operator console featuring secure audiovisual connectivity to support remote procedural execution.
Robotic Assisted Endovascular Systems Market Leading Companies Driving Competitive Growth
Major companies operating in the robotic assisted endovascular systems market are Johnson & Johnson, Siemens Healthineers AG, Corindus Vascular Robotics Inc., Cordis Corporation, MicroPort Scientific Corporation, Hansen Medical Inc., Robocath S.A.S., Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.
Access The Complete Robotic Assisted Endovascular Systems Market Report:
Robotic Assisted Endovascular Systems Market Leading Geography: Which Region Generates The Most Revenue?
Europe was the largest region in the robotic assisted endovascular systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic assisted endovascular systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model